September 2024 PMID 39171545

Paper-based analytical device for point-of-care nucleic acid quantification combining CRISPR/Cas12a and a personal glucose meter.

Yohei Tanifuji, Guodong Tong, Yuki Hiruta, Daniel Citterio

Mentions

3
Peak: 2 in Sep 2025
across 2 sources since Aug 2024

Extended reach

4,016
potential audience

Total likes

0

Video views

3,371

Mentions per month

Aug 2024 – Sep 2025

Where it's discussed

  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussions show strong support for the device's promise, with comments emphasizing its simplicity and practical advantages, such as using existing glucose meters. Words like 'game-changing' and 'neat approach' convey enthusiasm, while technical references to detection limits and stability reflect the community's engaged, detail-oriented perspective.

AgreementModerate agreement

Most discussions express support for the innovative combination of CRISPR technology with simple detection tools, indicating broad agreement on its potential.

InterestHigh interest

Posts demonstrate high curiosity and enthusiasm for the device’s applications, especially in point-of-care diagnostics.

EngagementModerate engagement

Several comments delve into technical aspects, such as stability and detection limits, showing moderate to deep engagement.

ImpactHigh impact

Users highlight the potential for this device to revolutionize viral detection in resource-limited settings, indicating perceived high impact.

Abstract in brief

  • This paper introduces a simple, paper-based device that uses CRISPR-Cas12a technology combined with a personal glucose meter to quickly and easily measure DNA from viruses like HPV without complicated lab procedures.
  • The device works by using magnetic beads and pre-loaded reagents that are freeze-dried with trehalose for stability, allowing for straightforward sample processing and detection through a glucose meter.
  • The method has a detection limit of 57 pM, comparable to other CRISPR-based tests, and remains stable for up to 4 weeks, making it practical for real-world, point-of-care use.]

Top posts

Most liked on X and Bluesky
Phage Papers
@Phage_Papers · X

Paper-based analytical device for point-of-care nucleic acid quantification combining CRISPR/Cas12a and a personal glucose meter https://t.co/Iy9asnBOKJ

Aug 22, 2024 · 646 followers View post →

All mentions

Phage Papers
@Phage_Papers · X

Paper-based analytical device for point-of-care nucleic acid quantification combining CRISPR/Cas12a and a personal glucose meter https://t.co/Iy9asnBOKJ

Aug 22, 2024 · 646 followers View post →